News

Gorilla Technology Group Inc. GRRR recently announced a $105 million direct offering of common stock. This includes a $100 million investment from a new institutional investor and additional funds

For Immediate Release

Chicago, IL – July 1, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and

Incyte INCY has put up a good performance in the past three months. Shares of the company have gained 9.2% against the industry’s decline of 1.3%. The stock has also outperformed the sector in the

UnitedHealth Group Incorporated UNH was recently dropped from several Russell growth-style indices including the Russell Top 200 Growth, Russell 1000 Growth, and Russell 3000 Growth, effective June

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm

For Immediate Release

Chicago, IL – July 1, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and

AT&T, Inc. T has gained 26.7% over the past year compared with the Wireless National industry’s growth of 10.3%. The stock has also outperformed the Zacks Computer & Technology sector and the S&P

An updated edition of the May 16, 2025, article.Nuclear energy is emerging as a crucial solution for meeting the growing global demand for electricity while supporting the transition to cleaner

Chewy CHWY demonstrated a noticeable acceleration in active customer growth in the first quarter of fiscal 2025, reflecting the success of its ongoing customer acquisition and retention strategies

For Immediate Release

Chicago, IL – July 1, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and

For Immediate Release

Chicago, IL – July 1, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and

Moderna MRNA announced that its seasonal influenza vaccine candidate, mRNA-1010, achieved superior relative vaccine efficacy (rVE) than an approved flu shot marketed by GSK plc GSK in a phase III

OppFi’s OPFI customer-centric approach serves as its paramount differentiator within the alternative lending platform market. While most players vie for market share, OppFi’s priority toward

Shares of Strattec Security (STRT) have been strong performers lately, with the stock up 14.7% over the past month. The stock hit a new 52-week high of $66.1 in the previous session. Strattec

Have you been paying attention to shares of Walt Disney (DIS)? Shares have been on the move with the stock up 9.8% over the past month. The stock hit a new 52-week high of $124.69 in the previous